Summary
iShares Genomics Immunology and Healthcare ETF is an ETF - a fund traded on an exchange like a stock - run by IShares. Positions inside: 62. The ten largest make up 49% of the fund.
- Yearly costs
- 0.47%
- Fund size
- $321.3M
- Positions
- 62
- Dividend yield
- 0.66%
- Running since
- 2019
What speaks for it
Nothing stands out in its favour.
What to watch
- In the last five years its price once dropped by 69% from its high.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- +1.6%
- 3 months
- +31%
- This year
- +64%
- 1 year
- +71%
- 3 years
- +142%
- 5 years
- -13%
- Avg. market cap
- $56.0B
- P/E
- -
- Forward P/E
- -
- P/S
- 5.5x
- P/B
- 3.7x
- P/FCF
- -
- EV/EBITDA
- -
- Dividend yield
- 0.38%
- ROIC
- -11.4%
- ROE
- -16.9%
- Gross margin
- 37.1%
- Operating margin
- -129.6%
- Net margin
- -131.8%
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 1.11
Weighted average of the 46 largest companies, which make up 97% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Moderately concentrated- 1 MRModerna MRNA 12%
- 2 TWTwist Bioscience TWST 5.6%
- 3 IOIovance Biotherapeutics, Inc. IOVA 4.9%
- 4 GMGenmab A/S GMAB.CO 4.6%
- 5 45Takeda Pharmaceutical Company Limited 4502.T 3.8%
- 6 RERegeneron Pharmaceuticals REGN 3.7%
- 7 RVRevolution Medicines RVMD 3.6%
- 8 EXExelixis EXEL 3.5%
- 9 MRMerck & Co. MRK 3.5%
- 10 CACaris Life Sciences, Inc. CAI 3.5%
Positions in the fund: 62. The ten largest make up 49% of it.
Composition as of Oct 23, 2026.
Where is it spread?
Spread outBy country
- United States 66%
- Germany 6.2%
- France 5.5%
- Japan 5.2%
- Other countries 17%
By company size
- Mega cap 7.0%
- Large cap 51%
- Mid cap 27%
- Small cap 14%
- Micro cap 0.2%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.
Largest country: United States (66%). Largest size group: Large cap (51%).
What does it cost me?
Usual costs- A year from $10,000
- $47.00
- Over 20 years
- $2,277
From every $10,000 invested the fund takes $47.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,277.
How has it done?
Losing value- A year on average, 5 years
- -2.9%
- Deepest drop
- -69%
- Yearly volatility
- 30%
Average yearly decline over the last five years: 2.9%. Deepest drop in these years: 69% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 0.66%
- Payments a year
- 2
- Last payment
- $0.13
Over the last 12 months it paid $0.28 per share, which is 0.66% of today's price. The last payment was $0.13 on Jun 15, 2026.
Is it easy to buy and sell?
Yes- Traded a day
- $4.91M
- Shares a day
- 115K
On an average day about $4.91M of the fund changes hands.
How expensive are the companies inside?
Usual valuation- Average Bulios Score
- 45 out of 100
Weight by Bulios Fair Price
- Undervalued 31%
- Fairly valued 25%
- Overvalued 44%
By Fair Price, 44% of the rated weight comes out as overvalued.
Counted from its largest companies (46), which make up 97% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
GN GNMX Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF | United States | 0.35% | $1.98M | - | - | 30% |
WD WDNA WisdomTree BioRevolution Fund | United States | 0.45% | $3.00M | +46% | Pays out | 29% |
GN GNOM Global X - Genomics & Biotechnology ETF | United States | 0.50% | $104.6M | +63% | Pays out | 29% |
BB BBP Virtus Biotech ETF | United States | 0.34% | $41.6M | +44% | Reinvests | 25% |
20 203780.KS MiraeAsset TIGER NASDAQ BIO ETF | South Korea | 0.30% | $78.3M | +28% | Reinvests | 24% |
IB IBBQ Invesco Nasdaq Biotechnology ETF | United States | 0.19% | $81.8M | +37% | Pays out | 23% |